A Focus on Robotics and AI Across All Healthcare Procedures
We invest in the robotics and AI ecosystem across all medical procedures
to improve patient outcomes, boost labor productivity, and
lower costs for all aspects of the healthcare system.
The Puma VC Difference
Puma Venture Capital was co-founded by Amit Hazan and Dr. Vipul Patel in 2023 with the goal of unifying top notch medtech investment professionals with surgeon venture partners that are key opinion leaders in their respective specialties.
Investment Expertise
.png)
Puma VC’s investment team brings a rare combination of public- and private-market investing rigor and hands-on robotics operating experience. Co-founder Amit Hazan brings over 25 years of medical technology research and investing experience that spans both Wall Street—most recently a Managing Director at Goldman Sachs— and Venture Capital, with a deep expertise in medical robotics. Dr. Fred Moll is perhaps the leading voice in all of medical robotics today. He is a pioneering entrepreneur in surgical robotics who co-founded Intuitive Surgical (creator of the da Vinci platform), later founded and led multiple robotics companies, including Auris Health, and has been a successful venture capitalist for the past decade. Scott Zinober has been one of the top healthcare investors on Wall Street for over two decades; a former Senior Portfolio Manager at Viking Global Investors where he led a multi-billion dollar portfolio across all healthcare sectors, and managed a team focused on identifying and researching healthcare opportunities. Together, Amit, Fred, and Scott bring complementary perspectives—technology, clinical/operator, and investment discipline—to identify and support the next generation of robotics and medical technology leaders.
Powered by Surgeons
Our venture firm is powered by more than 20 surgeons who are key opinion leaders across the most relevant specialties, and led by our co-founder Dr. Vipul Patel. Their collective wisdom, deep relationships and access, and entrepreneurial spirit will continue to serve as a great asset for both our investment process and our portfolio companies in every stage of their life cycle.
What We Invest In
We invest in robotic and AI systems transforming medical procedures — from intelligent platforms to embodied agents and next-generation instruments — improving outcomes and reducing system costs.
ROBOTIC & AUTONOMOUS SYSTEMS
INTELLIGENCE & EMBODIED AI AGENTS
INTELLIGENT INFRASTRUCTURE
FOUNDATIONAL ROBOTIC SYSTEMS ENABLING MEDICAL PROCEDURES ACROSS SETTINGS — FROM HOSPITALS AND ASCS TO CLINICS — SPANNING BOTH COMPLEX AND ROUTINE WORKFLOWS.
AI SYSTEMS AND EMBODIED AGENTS THAT PERCEIVE, DECIDE, AND ACT WITHIN PROCEDURE ENVIRONMENTS — ENABLING AUTONOMY, CLOSED-LOOP CONTROL, AND NEXT-GENERATION ROBOTIC CAPABILITY.
DIGITAL ECOSYSTEMS, REMOTE/CONNECTED CARE PLATFORMS, CYBERSECURITY, AND NETWORK-ENABLING TECHNOLOGIES THAT POWER THE PROCEDURAL ECOSYSTEM.
PROCEDURAL
VISUALIZATION & NAVIGATION
NEXT-GEN INSTRUMENTATION
IMAGING, NAVIGATION, SENSING, AND INTRA-PROCEDURE DIAGNOSTICS THAT ENABLE EARLIER DETECTION, PRECISE TARGETING, AND BETTER REAL-TIME DECISION SUPPORT.
SMART INSTRUMENTS AND THERAPEUTIC DEVICES THAT EXTEND ROBOTIC CAPABILITY, SIMPLIFY WORKFLOWS, AND IMPROVE PROCEDURAL PERFORMANCE.
